Ab externo implantation of the MicroShunt, a poly(styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review

Sadruddin O., Pinchuk L., Angeles R., Palmberg P.

2019
Eye and vision

View publication

Therapeutic Area

Glaucoma
Technology

Other

Affiliations

Santen Inc, Emeryville, CA USA; InnFocus Inc., a Santen Company, Miami, FL USA; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine,
Miami, FL USA

Related Publications

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: 2-year Results from a Randomized, Multicenter Study

Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, Grover DS, Khatana AK, Lee B, Nguyen T, Stiles MC, Sadruddin O, Khaw PT.

Omidenepag Isopropyl in Latanoprost Low/Non-Responders with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3, Non-Randomized, Two-Phase, Open-Label Study

Panarelli JF, Bowden EC, Tepedino ME, Odani-Kawabata N, Pei Z, McLaurin EB, Ropo A.

The Development of a SIBS Shunt to Treat Glaucoma

Pinchuk L.

View all Glaucoma publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022